Literature DB >> 3015006

Influence of acyclovir and bucyclovir on nucleotide pools in cells infected with herpes simplex virus type 1.

A H Karlsson, J G Harmenberg, B E Wahren.   

Abstract

The effects of the acyclic guanosine analogs acyclovir (ACV) and (R)-9-(3,4-dihydroxybutyl)guanine (bucyclovir, BCV) on the deoxyribonucleoside triphosphate (dNTP) pools of herpes simplex type 1 (HSV-1)-infected African green monkey kidney (GMK) and human embryonic lung fibroblast (HL) cells were investigated. HSV-1 infection increased the dNTP pools in both cell types compared with those in uninfected cells. Mock-infected GMK cells showed a 10-fold-higher dTTP concentration than comparable HL cells. ACV or BCV treatment of HSV-1-infected cells yielded further increases of the dNTP pools. ACV- or BCV-treated, HSV-1-infected HL cells showed 20- to 50-fold-higher concentrations of ACV triphosphate and BCV triphosphate, respectively, than similarly treated GMK cells. This is in accord with previous results, which showed that ACV and BCV are less active in GMK cells than in HL cells. This difference in activity is attributed to the substantial deoxythymidine pools previously found in GMK cells. The results are discussed in relation to known metabolic and kinetic parameters.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3015006      PMCID: PMC284160          DOI: 10.1128/AAC.29.5.821

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine.

Authors:  G B Elion; P A Furman; J A Fyfe; P de Miranda; L Beauchamp; H J Schaeffer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

2.  A rapid and sensitive high pressure liquid chromatography assay for deoxyribonucleoside triphosphates in cell extracts.

Authors:  C Garrett; D V Santi
Journal:  Anal Biochem       Date:  1979-11-01       Impact factor: 3.365

3.  An analytical system for rapid separation of tissue nucleotides at low pressures on conventional anion exchangers.

Authors:  J X Khym
Journal:  Clin Chem       Date:  1975-08       Impact factor: 8.327

4.  The chemotherapeutic exploitation of virus-specified enzymes.

Authors:  G B Elion
Journal:  Adv Enzyme Regul       Date:  1980

5.  Phosphorylation of acyclovir (acycloguanosine) monophosphate by GMP kinase.

Authors:  W H Miller; R L Miller
Journal:  J Biol Chem       Date:  1980-08-10       Impact factor: 5.157

6.  Isolation and characterization of acyclovir-resistant mutants of herpes simplex virus.

Authors:  H J Field; G Darby; P Wildy
Journal:  J Gen Virol       Date:  1980-07       Impact factor: 3.891

7.  Metabolism and mode of action of (R)-9-(3,4-dihydroxybutyl)guanine in herpes simplex virus-infected vero cells.

Authors:  K Stenberg; A Larsson; R Datema
Journal:  J Biol Chem       Date:  1986-02-15       Impact factor: 5.157

8.  Comparative efficacy of antiherpes drugs in different cell lines.

Authors:  E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

9.  Inhibition of purified human and herpes simplex virus-induced DNA polymerases by 9-(2-hydroxyethoxymethyl)guanine triphosphate. Effects on primer-template function.

Authors:  D Derse; Y C Cheng; P A Furman; M H St Clair; G B Elion
Journal:  J Biol Chem       Date:  1981-11-25       Impact factor: 5.157

10.  Influence of cells and virus multiplicity on the inhibition of herpesviruses with acycloguanosine.

Authors:  J Harmenberg; B Wahren; B Oberg
Journal:  Intervirology       Date:  1980       Impact factor: 1.763

View more
  6 in total

1.  Strategic design and three-dimensional analysis of antiviral drug combinations.

Authors:  M N Prichard; L E Prichard; C Shipman
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

2.  Acyclic guanosine analogs as inhibitors of human cytomegalovirus.

Authors:  B Wahren; A Larsson; U Rudén; A Sundqvist; E Sølver
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

3.  Effects of ribonucleotide reductase inhibition on pyrimidine deoxynucleotide metabolism in acyclovir-treated cells infected with herpes simplex virus type 1.

Authors:  A Karlsson; J Harmenberg
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

4.  Mode of action of 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine (BRL 39123) against herpes simplex virus in MRC-5 cells.

Authors:  R A Hodge; R M Perkins
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

5.  Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus.

Authors:  D L Earnshaw; T H Bacon; S J Darlison; K Edmonds; R M Perkins; R A Vere Hodge
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

6.  Pharmacokinetics and antiviral activity in simian varicella virus-infected monkeys of (R,S)-9-[4-hydroxy-2-(hydroxymethyl) butyl]guanine, an anti-varicella-zoster virus drug.

Authors:  D M Lake-Bakaar; G Abele; B Lindborg; K F Soike; R Datema
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.